| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.006 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |